Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates

22 Mar 2019

Abstract excerpt

Isavuconazole is the newest medical azole. We investigated EUCAST MICs for isavuconazole and seven comparators against 1,498 contemporary isolates (2016 to 2017).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Antimicrobial Resistance in Staphylococcus
Share to Fungal Infections and Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30910898
DOI: 10.1128/aac.00073-19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast IsolatesPMID 30910898Read ↗

Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolatesSemantic proximity Read ↗

Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.Semantic proximity Read ↗

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICsSemantic proximity Read ↗

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methodsSemantic proximity Read ↗

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.Semantic proximity Read ↗

A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical BreakpointsSemantic proximity Read ↗

In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents.Semantic proximity Read ↗

Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family AjellomycetaceaeSemantic proximity Read ↗

Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.Semantic proximity Read ↗

In Vitro Susceptibility of Fusarium to IsavuconazoleSemantic proximity Read ↗

Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.Semantic proximity Read ↗

Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining ChallengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.